{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:48:04Z","timestamp":1769813284449,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vaccine.2009.10.078","type":"journal-article","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T10:26:43Z","timestamp":1257244003000},"page":"699-706","source":"Crossref","is-referenced-by-count":2,"title":["Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge"],"prefix":"10.1016","volume":"28","author":[{"given":"Yong","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement A.","family":"Meseda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell A.","family":"Vassell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Merchlinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry P.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"October 29 (Suppl. 3)","key":"10.1016\/j.vaccine.2009.10.078_bib1","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0264-410X(99)00293-5","article-title":"Lessons from the eradication campaigns","volume":"17","author":"Henderson","year":"1999","journal-title":"Vaccine"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2009.10.078_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"Aug 6 (6)","key":"10.1016\/j.vaccine.2009.10.078_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/j.1326-5377.1977.tb114544.x","article-title":"Adverse reactions after smallpox vaccination","volume":"2","author":"Feery","year":"1977","journal-title":"Med J Aust"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.10.078_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2009.10.078_bib5","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"August 15 (4)","key":"10.1016\/j.vaccine.2009.10.078_bib6","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J Immunol"},{"issue":"October 1 (7)","key":"10.1016\/j.vaccine.2009.10.078_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1086\/520936","article-title":"Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine-induced immunity","volume":"196","author":"He","year":"2007","journal-title":"J Infect Dis"},{"issue":"February 26 (10)","key":"10.1016\/j.vaccine.2009.10.078_bib8","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","article-title":"Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge","volume":"25","author":"Hooper","year":"2007","journal-title":"Vaccine"},{"issue":"January 26 (7)","key":"10.1016\/j.vaccine.2009.10.078_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2009.10.078_bib10","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JVI.01854-07","article-title":"Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","volume":"82","author":"Berhanu","year":"2008","journal-title":"J Virol"},{"issue":"November 15 (22)","key":"10.1016\/j.vaccine.2009.10.078_bib11","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (Part 5)","key":"10.1016\/j.vaccine.2009.10.078_bib12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.10.078_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"August 5 (16)","key":"10.1016\/j.vaccine.2009.10.078_bib14","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"March 30 (13)","key":"10.1016\/j.vaccine.2009.10.078_bib15","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"September 1 (2)","key":"10.1016\/j.vaccine.2009.10.078_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","volume":"339","author":"Meseda","year":"2005","journal-title":"Virology"},{"issue":"August 5 (31)","key":"10.1016\/j.vaccine.2009.10.078_bib17","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"December (Part 12)","key":"10.1016\/j.vaccine.2009.10.078_bib18","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol"},{"issue":"January 5 (1)","key":"10.1016\/j.vaccine.2009.10.078_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","article-title":"Poxvirus entry and membrane fusion","volume":"344","author":"Moss","year":"2006","journal-title":"Virology"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2009.10.078_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/0022-1317-50-1-89","article-title":"Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia","volume":"50","author":"Payne","year":"1980","journal-title":"J Gen Virol"},{"issue":"January 20 (2)","key":"10.1016\/j.vaccine.2009.10.078_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"February 1 (1)","key":"10.1016\/j.vaccine.2009.10.078_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2009.10.078_bib23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J Virol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2009.10.078_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0042-6822(91)90901-M","article-title":"A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope","volume":"181","author":"Gordon","year":"1991","journal-title":"Virology"},{"issue":"August 1 (1)","key":"10.1016\/j.vaccine.2009.10.078_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"February 1 (1)","key":"10.1016\/j.vaccine.2009.10.078_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.10.078_bib27","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.10.078_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/JVI.61.2.395-404.1987","article-title":"A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers","volume":"61","author":"Rodriguez","year":"1987","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.10.078_bib29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J Virol"},{"issue":"January (Part 1)","key":"10.1016\/j.vaccine.2009.10.078_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1099\/0022-1317-81-1-47","article-title":"The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles","volume":"81","author":"Sanderson","year":"2000","journal-title":"J Gen Virol"},{"issue":"May (Part 5)","key":"10.1016\/j.vaccine.2009.10.078_bib31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","article-title":"Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions","volume":"83","author":"Ramirez","year":"2002","journal-title":"J Gen Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.10.078_bib32","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/JVI.65.10.5631-5635.1991","article-title":"The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals","volume":"65","author":"Lai","year":"1991","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.10.078_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JVI.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.10.078_bib34","doi-asserted-by":"crossref","unstructured":"Moss B, Earl PL. Overview of the vaccinia virus expression system. Curr Protoc Mol Biol 2002 November;Chapter 16:Unit 16.5.","DOI":"10.1002\/0471142727.mb1615s60"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.10.078_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JCM.27.5.947-951.1989","article-title":"Single-step, chromogenic Limulus amebocyte lysate assay for endotoxin","volume":"27","author":"Lindsay","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"April 15 (8)","key":"10.1016\/j.vaccine.2009.10.078_bib36","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.4049\/jimmunol.176.8.4940","article-title":"CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus","volume":"176","author":"Pedras-Vasconcelos","year":"2006","journal-title":"J Immunol"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2009.10.078_bib37","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1128\/JVI.00935-06","article-title":"Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells","volume":"80","author":"Gedey","year":"2006","journal-title":"J Virol"},{"issue":"August 1 (3)","key":"10.1016\/j.vaccine.2009.10.078_bib38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/376557","article-title":"Development of a novel vaccinia-neutralization assay based on reporter-gene expression","volume":"188","author":"Manischewitz","year":"2003","journal-title":"J Infect Dis"},{"issue":"March 11 (6979)","key":"10.1016\/j.vaccine.2009.10.078_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.10.078_bib40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/15058","article-title":"Advances in vaccine adjuvants","volume":"17","author":"Singh","year":"1999","journal-title":"Nat Biotechnol"},{"issue":"June","key":"10.1016\/j.vaccine.2009.10.078_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunol Rev"},{"issue":"June 19 (7198)","key":"10.1016\/j.vaccine.2009.10.078_bib42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.10.078_bib43","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1128\/JVI.70.11.7641-7653.1996","article-title":"Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis","volume":"70","author":"Rodriguez","year":"1996","journal-title":"J Virol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2009.10.078_bib44","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.10.078_bib45","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2009.10.078_bib46","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J Virol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2009.10.078_bib47","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.10.078_bib48","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.10.078_bib49","doi-asserted-by":"crossref","first-page":"e1000480","DOI":"10.1371\/journal.ppat.1000480","article-title":"Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome","volume":"5","author":"Delaloye","year":"2009","journal-title":"PLoS Pathog"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2009.10.078_bib50","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/JVI.00568-08","article-title":"Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge","volume":"82","author":"Fogg","year":"2008","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:19:09Z","timestamp":1590232749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09016089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0264410X09016089"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}